| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/19/2001 | EP1133298A1 Compositions comprising cefuroxime axetil |
| 09/19/2001 | EP1133297A1 Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline |
| 09/19/2001 | EP1133296A1 Novel therapeutic application of nicergoline |
| 09/19/2001 | EP1133295A1 Use of nicergoline for treating spasmodism |
| 09/19/2001 | EP1133294A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 09/19/2001 | EP1133293A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
| 09/19/2001 | EP1133292A1 A new pharmaceutical composition |
| 09/19/2001 | EP1133291A1 Methods of treating thrombocytopenia |
| 09/19/2001 | EP1133290A1 Use of effectors of the central cholinergic nervous system |
| 09/19/2001 | EP1133289A1 Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia |
| 09/19/2001 | EP1133288A1 The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence |
| 09/19/2001 | EP1133287A2 Use of 17-ketosteroids for the treatment of hepatitis c virus and other togaviruses |
| 09/19/2001 | EP1133286A1 Solid lipidic nanospheres suitable to a fast internalization into cells |
| 09/19/2001 | EP1133285A1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 09/19/2001 | EP1133284A1 New process |
| 09/19/2001 | EP1133283A1 A method of producing drug particles |
| 09/19/2001 | EP1133279A1 Method of producing vitamin powders |
| 09/19/2001 | EP1133278A2 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 09/19/2001 | EP1133275A1 Use of a synergistic mixture of polyphenols and vitamin compounds in cosmetic and dermatological compositions and methods for capturing free radicals on the skin and skin appendices |
| 09/19/2001 | EP1133273A1 Method for inhibiting dental resorptive lesions |
| 09/19/2001 | EP1133230A1 Dosage formulations for acetylcholinesterase inhibitors |
| 09/19/2001 | EP1015416B1 Method for the preparation of citalopram |
| 09/19/2001 | EP0948522A4 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 09/19/2001 | EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 09/19/2001 | EP0910389A4 Method of promoting bone growth with hyaluronic acid and growth factors |
| 09/19/2001 | EP0889901B1 Process and intermediates for the synthesis of lhrh antagonists |
| 09/19/2001 | EP0880522B1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES AMPA AND NMDA RECEPTORS ANTAGONISTS, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME |
| 09/19/2001 | EP0874849B1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives |
| 09/19/2001 | EP0871434B1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 09/19/2001 | EP0871420B1 Triacetin as a transdermal penetration enhancer |
| 09/19/2001 | EP0869954B1 Heterocyclic compounds for use in the treatment of neurogenic inflammation |
| 09/19/2001 | EP0869952B1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
| 09/19/2001 | EP0866804B1 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 09/19/2001 | EP0862634B1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 09/19/2001 | EP0853616B1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 09/19/2001 | EP0839144B1 Piperazine derivatives as therapeutic agents |
| 09/19/2001 | EP0820443B1 Heterocyclic compounds for treating diabetes |
| 09/19/2001 | EP0804206B1 Antifungal agent containing crotamiton, and salicyclic aldehyde |
| 09/19/2001 | EP0800516B1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| 09/19/2001 | EP0770077B1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 09/19/2001 | EP0728140B1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 09/19/2001 | EP0710111B1 Hormonal agent for the treatment of acne and its use |
| 09/19/2001 | EP0692964B1 Ionene polymers as anthelmintics in animals |
| 09/19/2001 | EP0675712B1 Reduction of hair growth employing sulfhydryl reactive compounds |
| 09/19/2001 | EP0612244B1 Endothelin receptor antagonists |
| 09/19/2001 | EP0594667B1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 09/19/2001 | EP0538297B1 Antiviral tetrahydroimidazo 1,4]benzodiazepin-2-(thio)ones |
| 09/19/2001 | EP0500864B1 Antimuscarinic bronchodilators |
| 09/19/2001 | CN1313862A Novel 17-halogenated 19-Nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 09/19/2001 | CN1313861A 2-(purin-9-YL)-tetrahydrofuran-3,4-diolderivatives |
| 09/19/2001 | CN1313860A 2-(purin-9-YL)-tetrahydrofuran-3,4-diol, derivatives |
| 09/19/2001 | CN1313858A Manufacture of 1,3-oxathiolane nucleosides |
| 09/19/2001 | CN1313856A Thiazoline acid derivatives |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1313854A Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 09/19/2001 | CN1313853A Oxindole derivatives as growth hormone releasers |
| 09/19/2001 | CN1313846A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 09/19/2001 | CN1313776A Therapeutic agents for allergic diseases |
| 09/19/2001 | CN1313773A Antigenic peptides derived from telomerase |
| 09/19/2001 | CN1313769A Pharmaceutical combination comprising A COX-2 inhibitor and a iNOS inhibitor |
| 09/19/2001 | CN1313768A Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antivirual agents containing both |
| 09/19/2001 | CN1313767A Carbamate and urea compositions and neurotrophic uses |
| 09/19/2001 | CN1313766A DNA-cleaving antitumor agents |
| 09/19/2001 | CN1313765A Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 09/19/2001 | CN1313764A New use of taxoid derivatives |
| 09/19/2001 | CN1313763A Natural physiologically active substances efficacious against fish diseases and fish feeds containing the same |
| 09/19/2001 | CN1313762A Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 09/19/2001 | CN1313758A Injectable aqueous dispersions of propofol |
| 09/19/2001 | CN1313755A Oral mucoadhesive compositions containing gastrointestinal actives |
| 09/19/2001 | CN1313754A Oral liquid mucoadhesive compositions |
| 09/19/2001 | CN1313753A Skin and tissue care and/or treatment agent |
| 09/19/2001 | CN1313742A Treatment of female sexual dysfunction |
| 09/19/2001 | CN1313343A N-terminal modified protein compositions and methods therefor |
| 09/19/2001 | CN1313286A S type 4-substituted hydroxypyranoindolidine compound and its derivatives and preparation thereof |
| 09/19/2001 | CN1313284A N-(3-benzofuryl) urea derivative |
| 09/19/2001 | CN1313280A Benzheterocyclic derivatives |
| 09/19/2001 | CN1313124A Ointment for treating burn and its preparing process |
| 09/19/2001 | CN1313108A Composite non-opium medicine for dropping drugs |
| 09/19/2001 | CN1313106A Broad-spectrum antibacterial Huangru Ointment for treating deep burn |
| 09/19/2001 | CN1313089A Iron-supplementing instant effervescent particles and its preparing process |
| 09/19/2001 | CN1313088A Liquid propanethiophenyl imidzole for expelling parasites from body of livestock and its preparing process |
| 09/19/2001 | CN1313087A Application of tea pigment in treating diseases in respiratory system |
| 09/19/2001 | CN1313086A Use of fatty materials for prevention or reduction of microorganism adhere on skin and/or mucous membrane |
| 09/19/2001 | CN1313085A Application of cinnamic acid in controlling morbility of I-type diabetes |
| 09/19/2001 | CN1313084A Application of tea polyphenol in medicine to treat diseases in respiratory system |
| 09/19/2001 | CN1313032A Mixture of fungicidal compounds |
| 09/19/2001 | CN1071333C Quinoline derivative |
| 09/19/2001 | CN1071332C Enterokinetic benzamide |
| 09/19/2001 | CN1071331C Anti-helicobacter acyl derivatives of azolones |
| 09/19/2001 | CN1071330C Anti-helicobacter urea and thiourea derivatives of azolones |
| 09/19/2001 | CN1071329C Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/19/2001 | CN1071328C Arginine angalogues having nitric oxide synthase inhibitor activity |
| 09/19/2001 | CN1071327C Denzothiazine dioxides as endothelin antagonists |
| 09/19/2001 | CN1071325C Thiol derivatives with metallopeptidase inhibitory activity |
| 09/19/2001 | CN1071318C Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/19/2001 | CN1071315C Carbamate compounds and processes for preparing the same |
| 09/19/2001 | CN1071309C 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients |
| 09/19/2001 | CN1071124C Pharmaceutical composition for treating bed sore and ulcerous wound surface |
| 09/19/2001 | CN1071121C Medicine composition for treatment of tracheitis and asthma |
| 09/19/2001 | CN1071118C Pyrazolopyrimidone for treating impotence |